Tempong, Jerome F.
HRN: 05-27-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
CEFTRIAXONE 1G (VIAL)
03/01/2024
03/07/2024
IV
2g
Q 24H
Severe TBI, Multiple Soft Tissue Injuries Head And Extremities
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes